Antithyroid drugs for the treatment of hyperthyroidism caused by graves' disease

Endocrinology and Metabolism Clinics of North America

Volumn 27, Issue 1, 1998, Pages 225-247

  Cooper, D S ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CONTRAST MEDIUM; LITHIUM; POTASSIUM IODIDE; POTASSIUM PERCHLORATE; THIAMAZOLE; THYROXINE;

AGRANULOCYTOSIS; ANTIBODY TITER; ARTHRALGIA; DISEASE SEVERITY; DRUG EFFECT; DRUG METABOLISM; FEVER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNE RESPONSE; PRIORITY JOURNAL; REVIEW; SEPSIS; SKIN INFECTION; THYROID CRISIS; URTICARIA;

EID: 0031891955     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70308-X     Document Type: Article

References (150)

1. W.D. Alexander R.Mc.G. Harden D.A. Koutras Influence of iodine intake after treatment with antithyroid drugs Lancet 2 1965 866
2. H. Allannic R. Fauchet J. Orgiazzi Antithyroid drugs and Graves' disease: A prospective randomized evaluation of the efficacy of treatment duration J Clin Endocrinol Metab 70 1990 675
3. N. Amino O. Tanizawa H. Mori Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease J Clin Endocrinol Metab 55 1982 108
4. D. Arab D. Malatjalian R. Rittmaster Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole J Clin Endocrinol Metab 80 1995 1083
5. A. Aro J.K. Huttunen B.-A. Lamberg Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy of hyperthyroidism Acta Endocrinol 96 1981 321
6. F.S. Ashkar R.B. Katimus W.M. Smoak Thyroid storm treatment with blood exchange and plasmapheresis JAMA 214 1970 1275
7. F. Azizi Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goiter J Clin Endocrinol Metab 61 1985 374
8. F. Azizi Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants J Pediatr 128 1996 855
9. A. Baeza M. Aguayo M. Barria Rapid preoperative preparation in hyperthyroidism Clin Endocrinol 35 1991 439
10. G. Benker J. Esser G. Kahaly New therapeutic approaches in thyroidal autoimmune diseases Klin Wochenschr 68 1990 44
11. J. Berglund S. Christensen J. Dymling The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmo during the period 1970–1974 J Intern Med 229 1991 435
12. M.J. Berry J.D. Kieffer J.W. Harney Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase J Biol Chem 266 1991 14155
13. R.F. Bing F.D. Rosenthal Early remission in thyrotoxicosis produced by short courses of treatment Acta Endocrinol (Copenh) 100 1982 221
14. D. Bouma H. Kammer M. Greer Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease J Clin Endocrinol Metab 55 1982 1138
15. B. Brownlie H. Legge Thyrotropin results in euthyroid patients with a past history of hyperthyroidism Acta Endocrinol 122 1990 623
16. H.B. Burch L. Wartofsky Life-threatening thyrotoxicosis Endocrinol Metab Clin North Am 22 1993 263
17. S.T. Cooke G. Ratcliffe I. Fogelman Prevalence of inappropriate drug treatment in patients with hyperthyroidism BMJ [Clin Res] 291 1985 1491
18. D.S. Cooper Antithyroid drugs N Engl J Med 311 1984 1352
19. D.S. Cooper Propylthiouracil levels in hyperthyroid patients unresponsive to large doses Ann Intern Med 102 1985 328
20. D.S. Cooper Which antithyroid drug? Am J Med 80 1986 1165
21. D.S. Cooper Antithyroid drugs: To breast-feed or not to breast-feed Am J Obstet Gynecol 157 1987 234
22. D.S. Cooper H.H. Bode B. Nath Methimazole pharmacology in man: Studies using a newly developed radioimmunoassay for methimazole J Clin Endocrinol Metab 58 1984 473
23. D.S. Cooper D. Goldminz A.A. Levin Agranulocytosis associated with antithyroid drugs Ann Intern Med 98 1983 26
24. D.S. Cooper V.C. Saxe F. Maloof Studies of propylthiouracil using a newly developed radioimmunoassay J Clin Endocrinol Metab 52 1981 204
25. D.S. Cooper V.C. Saxe M. Meskell Acute effects of propylthiouracil (PTU) on thyroidal iodine organification and peripheral iodothyronine deiodination: Correlation with serum PTU levels measured by radioimmunoassay J Clin Endocrinol Metab 54 1982 101
26. P.J. Coyle J.E. Mitchell Thyroidectomy: Is Lugol's iodine necessary? Ann R Coll Surg Engl 64 1982 334
27. J. Crooks W.W. Buchanan E.J. Wayne Effect of pretreatment with methythiouracil on results of 131-I therapy BMJ I 1960 151
28. B. Davidson M. Soodak J.T. Neary The irreversible inactivation of thyroid peroxidase by metylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings Endocrinology 103 1978 871
29. D. D'Cruz A. Chesser C. Lightowler Case report—antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment Br J Rheumatol 34 1995 1090
30. T.W.A. DeBruin J.H. Bolk J.K. Bussemaker Graves' disease: Immunological and immunogenetic indicators of relapse BMJ [Clin Res] 296 1988 1292
31. G. Dickstein C. Shechner F. Adawi Lithium treatment in amiodarone-induced thyrotoxicosis Am J Med 102 1997 454
32. B. Ducornet J. Duprey Effents secondaires des antithyroidiens de synthese Ann Med Interne (Paris) 139 1988 410
33. G. Edan C. Massart B. Hody Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease BMJ 298 1989 359
34. C.H. Emerson A.J. Anderson W.J. Howard Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism J Clin Endocrinol Metab 40 1975 33
35. H. Engler A. Taurog M.L. Dorris Preferential inhibition of thyroxine and 3,5,3'-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin Endocrinology 110 1982 190
36. H. Escobar-Morreale J. Serrano-Gotarredona L. Villar Methimazole has no dose-related effect on the serum concentrations of soluble class I major histocompatibility complex antigens, soluble interleukin-2 receptor, and beta 2-microglobulin in patients with Graves' disease Thyroid 6 1996 29
37. O. Eshoj J. Kvetny E.F. Mogensen Prediction of the course of Graves' disease after medical antithyroid treatment Acta Med Scand 217 1985 225
38. J. Feely J. Crooks A.L. Forrest Propranolol in the surgical treatment of hyperthyroidism, including severely thyrotoxic patients Br J Surg 68 1981 865
39. U. Feldt-Rasmussen H. Schleusener P. Carayon Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease J Clin Endocrinol Metab 78 1994 98
40. J. Fradkin J. Wolff Iodide-induced thyrotoxicosis Medicine 62 1983 1
41. 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease J Clin Endocrinol Metab 62 1986 773
42. R.V.G. Garcia-Mayor C. Paramo R.L. Cano Antithyroid drug and Graves' hyperthyroidism: Significance of treatment duration and TRAb determination on lasting remission J Endocrinol Invest 15 1992 815
43. A. Gürlek V. Çobaukara M. Bayraktar Liver tests in hyperthyroidism: Effect of antithyroid therapy J Clin Gastroenterol 24 1997 180
44. G. Gwinup Prospective randomized comparison of propylthiouracil JAMA 239 1978 2457
45. K. Hashizume I. Ichikawa A. Sakurai Administration of thyroxine in treated Graves' disease N Engl J Med 324 1991 947
46. A.J. Hedley P.D. Bewsher S.J. Jones Late onset hypothyroidism after subtotal thyroidectomy for hyperthyroidism: Implications for long term follow-up Br J Surg 70 1983 740
47. A.J. Hedley R.E. Young S.J. Jones Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: Long-term follow up of 434 patients Clin Endocrinol (Oxf) 31 1989 209
48. J. Herrmann J.L. Kruskemper D.K. Grosser Peritonealdialyse in der thyreotoxischen krise Dtsch Med Wochenschr 95 1972 742
49. J.M. Hershman J.R. Givens C.E. Cassidy Long-term outcome of hyperthyroidism treated with antithyroid drugs J Clin Endocrinol Metab 26 1966 803
50. Y. Hikada N. Amino Y. Iwatani Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease J Clin Endocrinol Metab 77 1993 1667
51. J. Howard Treatment of thyrotoxicosis JAMA 202 1967 706
52. R. Jansson A. Karlsson P.A. Dahlberg Thyroxine, methimazole, and thyroid microsomal autoantibody titres in hypothyroid Hashimoto's thyroiditis BMJ [Clin Res] 290 1985 11
53. R. Jorde K. Ytre-Arne J. Stormer Short-term treatment of Graves' disease with methimazole in high versus low doses J Intern Med 238 1995 161
54. E. Jude J. Dale S. Kumar Treatment of thyrotoxicosis resistant to carbimazole with corticosteroids Postgrad Med J 72 1996 489
55. W.J. Kalk D. Durbach S. Kantor Postthyroidectomy thyrotoxicosis Lancet 1 1978 291
56. G. Kallner S. Vitols J. Ljunggren Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease J Intern Med 239 1996 525
57. K. Kawai H. Tamai S. Matsubayashi A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs Clin Endocrinol 43 1995 551
58. P. Klementschitsch K. Shen E.L. Kaplan Reemergence of thyroidectomy as treatment for Graves' disease Surg Clin North Am 59 1979 35
59. O. Kristenson H.H. Andersen G. Pallisgaard Lithium carbonate in the treatment of thyrotoxicosis Lancet 1 1976 603
60. S.-W. Kuo W.-S. Huang C.-A. Hu Effect of thyroxine administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during antithyroid drug therapy Eur J Endocrinol 131 1994 125
61. B. Lamberg J. Salmi G. Wagar Spontaneous hypothyroidism after antithyroid treatment of hyperthyroid Graves' disease J Endocrinol Invest 4 1981 399
62. P. Laurberg P.E.B. Hansen E. Iversen Goitre size and outcome of medical treatment of Graves' disease Acta Endocrinol (Copenh) 111 1986 39
63. S. Lennquist E. Jortso B.O. Anderberg Beta blockers compared with antithyroid drugs as preoperative treatment in hyperthyroidism: Drug tolerance, complications, and postoperative thyroid function Surgery 98 1985 1141
64. J.L. Leonard I.N. Rosenberg Thyroxine 5'-deiodinase activity of rat kidney: Observations on activation by thiols and inhibition by propylthiouracil Endocrinology 103 1978 2137
65. C. Levetan L. Wartofsky A clinical guide to the management of Graves' disease with radioactive iodine Endocr Pract 1 1995 205
66. H. Li J. Okuda T. Akamizu A hyperthyroid patient with Graves' disease who was strongly resistant to methimazole: Investigation on possible mechanisms of the resistance Endocr J 42 1995 697
67. Y.-F. Liaw M.-J. Huang K.-D. Fan Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism Ann Intern Med 118 1993 424
68. B.M. Lippe E.M. Landaw S.A. Kaplan Hyperthyroidism in children treated with long term medical therapy: Twenty-five percent remission every two years J Clin Endocrinol Metab 64 1987 1241
69. A.M. Madec H. Alllannic N. Genetet T lymphocyte subsets at various stages of hyperthyroid Graves' disease: Effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status J Clin Endocrinol Metab 62 1986 117
70. W.P. Maier B.M. Derrick A.D. Marks Long-term follow-up of patients with Graves' disease treated by subtotal thyroidectomy Am J Surg 147 1984 267
71. S.J. Mandel G.A. Brent P.R. Larsen Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis Thyroid 4 1994 129
72. C. Marcocci D. Gianchecchi I. Masini A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism J Endocrinol Invest 13 1990 513
73. E. Martino F. Lombardi-Aghini S. Mariotti Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole J Endocrinol Invest 9 1986 201
74. E. Martino S. Balzano L. Bartalena Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism J Endocrinol Invest 14 1991 847
75. Y. Mashio M. Beniko H. Kunita Treatment of hyperthyroidism with a small single daily dose of methimazole Acta Endocrinol (Copenh) 119 1988 139
76. A.M. McGregor M.M. Petersen S.M. McLachlan Carbimazole and the autoimmune response in Graves' disease N Engl J Med 303 1980 302
77. B. McIver P. Rae G. Beckett Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug N Engl J Med 334 1996 220
78. M. Messina P. Milani L. Gentile Initial treatment of thyrotoxic Graves' disease with methimazole: A randomized trial comparing different dosages J Endocrinol Invest 10 1987 291
79. M. Meyer-Gessner G. Benker S. Lederbogen Anthithyroid drug-induced agranulocytosis: Clinical experience with ten patients at one institution and review of the literature J Endocrinol Invest 17 1994 29
80. N. Momotani K. Ito N. Hamada Maternal hyperthyroidism and congenital malformation in the offspring Clin Endocrinol (Oxf) 20 1984 695
81. N. Momotani J. Noh H. Oyanagi Antithyroid drug therapy for Graves' disease during pregnancy N Engl J Med 315 1986 24
82. N. Nabil D.J. Miner M. Amatruda Methimazole: An alternative route of administration J Clin Endocrinol Metab 54 1982 180
83. K. Nagai H. Tamai T. Mukuta A follow-up study of 85 patients with Graves' disease in remission who developed undetectable serum thyroid-stimulating hormone concentrations using sensitive TSH assays Horm Res 35 1991 185
84. W. Nicholas R. Fischer R. Stevenson Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism South Med J 88 1995 973
85. K. Okamura H. Ikenoue A. Shiroozu Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism J Clin Endocrinol Metab 65 1987 719
86. B.P. O'Malley F.D. Rosenthal B.J. Northover Higher than conventional doses of carbimazole in the treatment of thyrotoxicosis Clin Endocrinol (Oxf) 29 1988 281
87. S. Page C. Sheard M. Herbert A comparison of 20 or 40 mg per day of carbimazole in the initial treatment of hyperthyroidism Clin Endocrinol 45 1996 511
88. N.A. Parwardhan M. Moront S. Rao Surgery still has a role in Graves' hyperthyroidism Surgery 114 1993 1108
89. R. Paschke M. Vogg R. Kristoferitsch Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease J Clin Endocrinol Metab 80 1995 2470
90. N.R. Peden M.C.K. Browning J. Feely The clinical and metabolic responses to early surgical treatment for hyperthyroid Graves' disease: A comparison of three preoperative treatment regimens Q J Med 221 1985 579
91. J. Pfeilschifter R. Ziegler Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: Effects on recurrence of hyperthyroidism and thyroid volume Eur J Endocrinol 136 1997 81
92. D.J. Reid Hyperthyroidism and hypothyroidism complicating the treatment of thyrotoxicosis Br J Surg 74 1987 1060
93. D. Reinwein G. Benker J.H. Lazarus A prospective randomized trial of antithyroid drug dose in Graves' disease therapy J Endocrinol Metab 76 1993 1516
94. D.P. Rennie A.M. McGregor D. Keast The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat Endocrinology 112 1983 326
95. R. Rittmaster H. Zwicker E. Abbott Effect of methimazole with or without exogenous l -thyroxine on serum concentrations of thyrotropin (THS) receptor antibodies in patients with Graves' disease J Clin Endocrinol Metab 81 1996 3283
96. J. Romaildini N. Bromberg R. Werner Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism J Clin Endocrinol Metab 57 1983 563
97. J.H. Romaldini M.C. Werner H.F. Rodriques Graves' disease and Hashimoto's thyroiditis: Effects of high doses of antithyroid drugs on thyroid autoantibody levels J Endocrinol Invest 9 1986 233
98. 131I) treatment of Graves' hyperthyroidism J Clin Endocrinol Metab 57 1983 250
99. E. Roti E. Gardini R. Minelli Methimazole and serum thyroid hormone concentrations in hyperthyroid patients: Effects of single and multiple daily doses Ann Intern Med 111 1989 181
100. E. Roti M. Montermini S. Roti The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients Arch Intern Med 148 1988 1919
101. E. Roti G. Robuschi E. Gardini Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease Clin Endocrinol (Oxf) 28 1988 305
102. E. Roti E. Gardini R. Minelli Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism J Clin Endocrinol Metab 76 1993 928
103. K. Samaras G. Marel Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone-induced thyroiditis Clin Endocrinol 45 1996 365
104. H. Schleusner J. Schwander C. Fischer Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease Acta Endocrinol (Copenh) 120 1989 689
105. R. Shabtai M.S. Shapiro D. Orenstein The antithyroid arthritis syndrome reviewed Arthritis Rheum 27 1984 227
106. B. Sharp A.W. Reed E.I. Tamagna Treatment of hyperthyroidism with sodium ipodate (Oragrafin) in addition to propylthiouracil and propranolol J Clin Endocrinol Metab 53 1981 622
107. S. Sherman L. Simonson P. Ladenson Clinical and socioeconomic predispositions to complicated thyrotoxicosis: A predictable and preventable syndrome? Am J Med 101 1996 192
108. D.W. Slingerland B.A. Burrows Long-term antithyroid treatment in hyperthyroidism JAMA 242 1979 2408
109. B. Solomon D. Glinoer R. Lagasse Current trends in the management of Graves' disease J Clin Endocrinol Metab 70 1990 1518
110. B. Solomon L. Wartofsky K. Burman Adjunctive cholestyramine therapy for thyrotoxicosis Clin Endocrinol 38 1993 39
111. D. Sugrue M. McEvoy J. Feely Hyperthyroidism in the land of Graves: Results of treatment by surgery, radio-iodine and carbimazole in 837 cases Q J Med 49 1980 51
112. S. Suzuki K. Ichikawa M. Nagai Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves' disease Arch Intern Med 157 1997 693
113. A. Syrenicz B. Gawronska-Szklarz J. Wojcicki Pharmacokinetic parameters of thiamazole in hyperthyroid patients responding rapidly and slowly to the treatment Pol J Pharmacol 43 1991 207
114. J. Tajiri S. Noguehi T. Murakami Antithyroid drug-induced agranulocytosis Arch Intern Med 150 1990 621
115. Y. Takaichi H. Tamai K. Honda The significance of antithyroglobulin and antithyroidal microsomal antibodies in patients with hyperthyroidism due to Graves' disease treated with antithyroidal drugs J Clin Endocrinol Metab 68 1989 1097
116. J. Takamatsu M. Sugawara K. Kuma Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease Ann Intern Med 100 1984 372
117. J. Takamatsu K. Kuma T. Mozai Serum triiodothyronine to thyroxine ratio: A newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease J Clin Endocrinol Metab 62 1986 980
118. L. Tallstedt G. Lundell O. Torring Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism N Engl J Med 326 1992 1733
119. H. Tamai T. Nakagawa O. Fukino Thionamide therapy in Graves' disease: Relation of relapse rate to duration of therapy Ann Intern Med 92 1980 488
120. H. Tamai T. Mukuta S. Matsubayashi Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony stimulating factor (rhG-CSF) J Clin Endocrinol Metab 77 1993 1356
121. H. Tamai I. Hayaki K. Kawai Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients J Clin Endocrinol Metab 80 1995 1481
122. H. Tamai T. Sudo A. Kimura Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves' disease Ann Intern Med 124 1996 490
123. A. Taurog M. Dorris A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil Endocrinology 124 1989 3038
124. 14C-labeled propylthiouracil in model in vitro system containing thyroid peroxidase Endocrinology 124 1989 3030
125. C.S. Teng R.T.T. Yeung Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: A prospective study J Clin Endocrinol Metab 50 1980 144
126. O. Törring L. Tallstedt G. Wallin Graves' hyperthyroidism: Treatment with antithyroid drugs, surgery, or radioiodine—a prospective randomized study J Clin Endocrinol Metab 81 1996 2986
127. T.H. Tötterman F.A. Karlsson M. Bengtsson Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease N Engl J Med 316 1987 15
128. N. Üntüvar R. Serter Y. Aral The effects of smoking on remission and relapse of Graves' disease Clin Endocrinol 46 1997 377
129. W. Vanderlaan V. Storrie A survey of the factors controlling thyroid function, with special recurrence to newer views on antithyroid substances Pharmacol Rev 7 1955 301
130. P. Van Dijke R. Heydendael M. Ke Kleine Methimazole, carbimazole, and congenital skin defects Ann Intern Med 106 1987 60
131. B. Velkeniers L. Vanhaelst R. Cytryn Treatment of hyperthyroidism with radioiodine: Adjunctive therapy with antithyroid drugs reconsidered Lancet 2 1998 1127
132. P. Vitti T. Rago L. Chiovato Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment Thyroid 7 1997 369
133. A.C. Vitug J.M. Goldman Hepatotoxicity from antithyroid drugs Horm Res 21 1985 229
134. B.A. Vogt Y. Kim C.J. Jennette Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children J Pediatr 124 1994 986
135. R. Volpe Evidence that the immunosuppressive effects of antithyroid drug are mediated through actions on the thyroid cell, modulating thyrocyte-immunocyte signaling: A review Thyroid 4 1994 217
136. M.R. Walter W.R. Bartlett Rectal administration of propylthiouracil in the treatment of Graves' disease Am J Med 88 1990 69
137. L. Wartofsky D. Glinoer B. Solomon Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States Thyroid 1 1991 129
138. L. Wartofsky Has the use of antithyroid drugs of Graves' disease become obsolete? Thyroid 3 1993 335
139. A. Weetman The immunomodulatory effects of antithyroid drugs Thyroid 4 1994 145
140. A.P. Weetman A.P. Pickerill P. Watson Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: The effect of treatment duration and immunogenetic susceptibility on relapse Q J Med 87 1994 337
141. K.W. Wenzel J.R. Lente Syndrome of persisting thyroid stimulating immunoglobulins and growth promotion of goiter combined with low thyroxine and high triiodothyronine serum levels in drug treated Graves' disease J Endocrinol Invest 6 1983 389
142. R. Werner J. Romaldini C. Farah Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease Thyroid 1 1991 293
143. K. Williams S.U. Nayak D. Becker Fifty years of experience with propylthiouracil-associated hepatotoxicity: What have we learned? J Clin Endocrinol Metab 82 1997 1727
144. R. Wilson L. Buchanan W. Fraser Do higher doses of carbimazole improve remission in Graves' disease Q J Med 89 1996 381
145. D. Wing K. Millar P. Koonings A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy Am J Obstet Gynecol 170 1 pt 1 1994 90
146. B. Winsa P. Dahlberg R. Jansson Factors influencing the outcome of thyrostatic drug therapy in Graves' disease Acta Endocrinol 122 1990 622
147. L.C. Wood S.H. Ingbar Hypothyroidism as a late sequela in patients with Graves' disease treated with antithyroid agents J Clin Invest 64 1979 1429
148. T. Yamada T. Aizawa Y. Koizumi Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease J Am Geriatr Soc 42 1994 513
149. E.T. Young N.R. Steel J.J. Talor Prediction of remission after antithyroid drug treatment in Graves' disease Q J Med 250 1988 175
150. A. Zaton A. Martinez J.M. DeGandarias The binding of thioureylene compounds to human serum albumin Biochem Pharmacol 37 1988 3127